SE0103644D0 - Therapeutic isoquinoline compounds - Google Patents
Therapeutic isoquinoline compoundsInfo
- Publication number
- SE0103644D0 SE0103644D0 SE0103644A SE0103644A SE0103644D0 SE 0103644 D0 SE0103644 D0 SE 0103644D0 SE 0103644 A SE0103644 A SE 0103644A SE 0103644 A SE0103644 A SE 0103644A SE 0103644 D0 SE0103644 D0 SE 0103644D0
- Authority
- SE
- Sweden
- Prior art keywords
- disorders
- sub
- compounds
- therapeutic
- isoquinoline compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Priority Applications (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0103644A SE0103644D0 (sv) | 2001-11-01 | 2001-11-01 | Therapeutic isoquinoline compounds |
PCT/SE2002/001988 WO2003037887A1 (en) | 2001-11-01 | 2002-11-01 | Therapeutic isoquinoline compounds |
PL02370058A PL370058A1 (en) | 2001-11-01 | 2002-11-01 | Therapeutic isoquinoline compounds |
CNA028262816A CN1608061A (zh) | 2001-11-01 | 2002-11-01 | 治疗用的异喹啉化合物 |
CA002464342A CA2464342A1 (en) | 2001-11-01 | 2002-11-01 | Therapeutic isoquinoline compounds |
JP2003540168A JP2005516896A (ja) | 2001-11-01 | 2002-11-01 | 治療用のイソキノリン化合物 |
US10/494,424 US20070010526A1 (en) | 2001-11-01 | 2002-11-01 | Therapeutic isoquinoline compounds |
MXPA04004076A MXPA04004076A (es) | 2001-11-01 | 2002-11-01 | Compuestos terapeuticos de isoquinolina. |
RU2004112423/04A RU2004112423A (ru) | 2001-11-01 | 2002-11-01 | Терапевтические изохинолиновые соединения |
HU0501089A HUP0501089A2 (en) | 2001-11-01 | 2002-11-01 | Therapeutic isoquinoline compounds and pharmaceutical compositions coutaining them |
EP02780244A EP1451172A1 (en) | 2001-11-01 | 2002-11-01 | Therapeutic isoquinoline compounds |
IL16151102A IL161511A0 (en) | 2001-11-01 | 2002-11-01 | Therapeutic isoquinoline compounds |
KR1020047006593A KR20050042223A (ko) | 2001-11-01 | 2002-11-01 | 치료용 이소퀴놀린 화합물 |
BR0213778-0A BR0213778A (pt) | 2001-11-01 | 2002-11-01 | Composição, método de tratamento de um ser humano ou animal que sofre de doenças, e, uso da composição |
IS7236A IS7236A (is) | 2001-11-01 | 2004-04-28 | Meðferðarfræðileg ísókínólínefnasambönd |
ZA200403240A ZA200403240B (en) | 2001-11-01 | 2004-04-29 | Therapeutic isoquinoline compounds. |
CO04039910A CO5580832A2 (es) | 2001-11-01 | 2004-04-30 | Compuestos isoquinolina terapeuticos |
NO20042154A NO20042154L (no) | 2001-11-01 | 2004-05-25 | Terapeutiske isokinolinforbindelser |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0103644A SE0103644D0 (sv) | 2001-11-01 | 2001-11-01 | Therapeutic isoquinoline compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0103644D0 true SE0103644D0 (sv) | 2001-11-01 |
Family
ID=20285846
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0103644A SE0103644D0 (sv) | 2001-11-01 | 2001-11-01 | Therapeutic isoquinoline compounds |
Country Status (18)
Country | Link |
---|---|
US (1) | US20070010526A1 (sv) |
EP (1) | EP1451172A1 (sv) |
JP (1) | JP2005516896A (sv) |
KR (1) | KR20050042223A (sv) |
CN (1) | CN1608061A (sv) |
BR (1) | BR0213778A (sv) |
CA (1) | CA2464342A1 (sv) |
CO (1) | CO5580832A2 (sv) |
HU (1) | HUP0501089A2 (sv) |
IL (1) | IL161511A0 (sv) |
IS (1) | IS7236A (sv) |
MX (1) | MXPA04004076A (sv) |
NO (1) | NO20042154L (sv) |
PL (1) | PL370058A1 (sv) |
RU (1) | RU2004112423A (sv) |
SE (1) | SE0103644D0 (sv) |
WO (1) | WO2003037887A1 (sv) |
ZA (1) | ZA200403240B (sv) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
US7101881B2 (en) * | 2003-06-11 | 2006-09-05 | Pfizer Inc | Tetrahydroquinolines |
JP2007501804A (ja) * | 2003-08-08 | 2007-02-01 | バーテックス ファーマシューティカルズ インコーポレイテッド | 電位開口型のナトリウムチャネルのインヒビターとして有用な組成物 |
EP2305352A1 (en) | 2004-04-02 | 2011-04-06 | Merck Sharp & Dohme Corp. | 5-alpha-reductase inhibitors for use in the treatment of men with metabolic and anthropometric disorders |
US7572805B2 (en) * | 2004-07-14 | 2009-08-11 | Bristol-Myers Squibb Company | Pyrrolo(oxo)isoquinolines as 5HT ligands |
JP2006056881A (ja) * | 2004-07-21 | 2006-03-02 | Takeda Chem Ind Ltd | 縮合環化合物 |
ES2257168B1 (es) | 2004-08-18 | 2007-06-01 | Laboratorios Del Dr Esteve, S.A. | Ligandos del receptor 5-ht7. |
US7211585B2 (en) | 2004-08-18 | 2007-05-01 | Laboratorios Del Dr. Esteve, S.A. | 5-HT7 receptor antagonists |
ES2257167B1 (es) * | 2004-08-18 | 2007-06-01 | Laboratorios Del Dr Esteve, S.A. | Inhibidores del receptor 5-ht7. |
EP1630158A1 (en) * | 2004-08-18 | 2006-03-01 | Laboratorios Del Dr. Esteve, S.A. | 5-HT7 receptor antagonists |
US7211584B2 (en) | 2004-08-18 | 2007-05-01 | Laboratorios Del Dr. Esteve, S.A. | 5-HT7 receptor ligands |
PL1858877T3 (pl) | 2005-01-14 | 2014-08-29 | Gilead Connecticut Inc | 1,3 podstawione diarylem moczniki jako modulatory aktywności kinazy |
WO2007024294A2 (en) | 2005-05-03 | 2007-03-01 | Cgi Pharmaceuticals, Inc. | Certain substituted ureas, as modulators of kinase activity |
US20080051387A1 (en) * | 2006-06-09 | 2008-02-28 | Yuelian Xu | Tetrahydropyrido[3,4-d]pyrimidines and related analogues |
BRPI0806371A2 (pt) | 2007-01-22 | 2011-09-13 | Gtx Inc | agentes ligação de receptor nuclear |
US9623021B2 (en) | 2007-01-22 | 2017-04-18 | Gtx, Inc. | Nuclear receptor binding agents |
US9604931B2 (en) | 2007-01-22 | 2017-03-28 | Gtx, Inc. | Nuclear receptor binding agents |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
MX2009013293A (es) | 2007-06-04 | 2010-02-15 | Synergy Pharmaceuticals Inc | Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos. |
SE531698C2 (sv) | 2007-07-12 | 2009-07-07 | Respiratorius Ab | Nya bronkdilaterande a,b-omättade amider |
ES2627848T3 (es) | 2008-06-04 | 2017-07-31 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos |
JP2011528375A (ja) | 2008-07-16 | 2011-11-17 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
KR20140003484A (ko) * | 2011-02-02 | 2014-01-09 | 아스테라스 세이야쿠 가부시키가이샤 | 테트라히드로이소퀴놀린 유도체 |
CN108676076A (zh) | 2011-03-01 | 2018-10-19 | 辛纳吉制药公司 | 制备鸟苷酸环化酶c激动剂的方法 |
CA2858328A1 (en) * | 2011-12-21 | 2013-06-27 | Actelion Pharmaceuticals Ltd | Heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
WO2014028669A1 (en) * | 2012-08-15 | 2014-02-20 | Biogen Idec Ma Inc. | Novel compounds for modulation of ror-gamma activity |
US8987461B2 (en) | 2012-12-06 | 2015-03-24 | Quanticel Pharmaceuticals, Inc. | Histone demethylase inhibitors |
US9221794B2 (en) | 2012-12-21 | 2015-12-29 | Epizyme, Inc. | PRMT5 inhibitors and uses thereof |
JP2016505000A (ja) | 2012-12-21 | 2016-02-18 | エピザイム,インコーポレイティド | Prmt5阻害剤およびその使用 |
WO2014100730A1 (en) | 2012-12-21 | 2014-06-26 | Epizyme, Inc. | Prmt5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof |
JP6678455B2 (ja) | 2012-12-21 | 2020-04-08 | エピザイム,インコーポレイティド | Prmt5阻害剤およびその使用 |
WO2014100716A1 (en) | 2012-12-21 | 2014-06-26 | Epizyme, Inc. | Prmt5 inhibitors and uses thereof |
US9315464B1 (en) | 2013-01-31 | 2016-04-19 | Nant Holdings Ip, Llc | Small molecule inhibitors of influenza A RNA-dependent RNA polymerase |
AR094929A1 (es) | 2013-02-28 | 2015-09-09 | Bristol Myers Squibb Co | Derivados de fenilpirazol como inhibidores potentes de rock1 y rock2 |
WO2014134391A1 (en) | 2013-02-28 | 2014-09-04 | Bristol-Myers Squibb Company | Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors |
JP2016514671A (ja) | 2013-03-15 | 2016-05-23 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼのアゴニストおよびその使用 |
AU2014235209B2 (en) | 2013-03-15 | 2018-06-14 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists combined with other drugs |
KR102272746B1 (ko) | 2013-06-05 | 2021-07-08 | 보슈 헬스 아일랜드 리미티드 | 구아닐레이트 사이클라제 c의 초순수 작용제, 및 이의 제조 및 사용 방법 |
CA2953572A1 (en) | 2014-08-04 | 2016-02-11 | Epizyme, Inc. | Prmt5 inhibitors and uses thereof |
JP7065951B2 (ja) | 2017-09-22 | 2022-05-12 | ジュビラント エピパッド エルエルシー | Pad阻害剤としての複素環式化合物 |
WO2019077631A1 (en) | 2017-10-18 | 2019-04-25 | Jubilant Biosys Limited | IMIDAZO-PYRIDINE COMPOUNDS FOR USE AS PAD INHIBITORS |
EP3707135A1 (en) | 2017-11-06 | 2020-09-16 | Jubilant Prodel LLC | Pyrimidine derivatives as inhibitors of pd1/pd-l1 activation |
EP3704120B1 (en) | 2017-11-24 | 2024-03-06 | Jubilant Episcribe LLC | Heterocyclic compounds as prmt5 inhibitors |
KR20200131845A (ko) | 2018-03-13 | 2020-11-24 | 주빌런트 프로델 엘엘씨 | Pd1/pd-l1 상호작용/활성화 억제제로서의 비사이클릭 화합물 |
WO2020183011A1 (en) | 2019-03-14 | 2020-09-17 | Institut Curie | Htr1d inhibitors and uses thereof in the treatment of cancer |
KR102589771B1 (ko) | 2021-11-30 | 2023-10-17 | 엘지전자 주식회사 | 스크롤 압축기 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT689536E (pt) * | 1993-03-16 | 2001-11-30 | Pfizer | Derivados de naftaleno |
DE69417427T2 (de) * | 1993-09-03 | 1999-11-25 | Smithkline Beecham Plc | Indol- und indolin-derivate als 5ht1d rezeptor antagonisten |
FR2744450A1 (fr) * | 1996-02-02 | 1997-08-08 | Pf Medicament | Nouvelles naphtylpiperazines derivees de cycloazanes substitues, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments |
JP2001506995A (ja) * | 1996-12-19 | 2001-05-29 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | N−ピペラジン−1−イルフェニル−ベンズアミド誘導体 |
DZ2376A1 (fr) * | 1996-12-19 | 2002-12-28 | Smithkline Beecham Plc | Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant. |
SE9702799D0 (sv) * | 1997-07-25 | 1997-07-25 | Astra Ab | New compounds |
CN1309654A (zh) * | 1998-07-20 | 2001-08-22 | 默克专利股份有限公司 | 联苯基衍生物 |
GB9926302D0 (en) * | 1999-11-05 | 2000-01-12 | Smithkline Beecham Plc | Novel compounds |
-
2001
- 2001-11-01 SE SE0103644A patent/SE0103644D0/sv unknown
-
2002
- 2002-11-01 RU RU2004112423/04A patent/RU2004112423A/ru not_active Application Discontinuation
- 2002-11-01 CN CNA028262816A patent/CN1608061A/zh active Pending
- 2002-11-01 CA CA002464342A patent/CA2464342A1/en not_active Abandoned
- 2002-11-01 WO PCT/SE2002/001988 patent/WO2003037887A1/en not_active Application Discontinuation
- 2002-11-01 US US10/494,424 patent/US20070010526A1/en not_active Abandoned
- 2002-11-01 MX MXPA04004076A patent/MXPA04004076A/es not_active Application Discontinuation
- 2002-11-01 JP JP2003540168A patent/JP2005516896A/ja active Pending
- 2002-11-01 IL IL16151102A patent/IL161511A0/xx unknown
- 2002-11-01 EP EP02780244A patent/EP1451172A1/en not_active Withdrawn
- 2002-11-01 BR BR0213778-0A patent/BR0213778A/pt not_active IP Right Cessation
- 2002-11-01 KR KR1020047006593A patent/KR20050042223A/ko not_active Application Discontinuation
- 2002-11-01 PL PL02370058A patent/PL370058A1/xx not_active Application Discontinuation
- 2002-11-01 HU HU0501089A patent/HUP0501089A2/hu unknown
-
2004
- 2004-04-28 IS IS7236A patent/IS7236A/is unknown
- 2004-04-29 ZA ZA200403240A patent/ZA200403240B/en unknown
- 2004-04-30 CO CO04039910A patent/CO5580832A2/es not_active Application Discontinuation
- 2004-05-25 NO NO20042154A patent/NO20042154L/no unknown
Also Published As
Publication number | Publication date |
---|---|
RU2004112423A (ru) | 2005-10-10 |
EP1451172A1 (en) | 2004-09-01 |
ZA200403240B (en) | 2005-04-07 |
KR20050042223A (ko) | 2005-05-06 |
US20070010526A1 (en) | 2007-01-11 |
IL161511A0 (en) | 2004-09-27 |
CO5580832A2 (es) | 2005-11-30 |
WO2003037887A8 (en) | 2005-03-17 |
BR0213778A (pt) | 2004-11-09 |
CA2464342A1 (en) | 2003-05-08 |
JP2005516896A (ja) | 2005-06-09 |
WO2003037887A1 (en) | 2003-05-08 |
IS7236A (is) | 2004-04-28 |
PL370058A1 (en) | 2005-05-16 |
MXPA04004076A (es) | 2004-07-23 |
HUP0501089A2 (en) | 2007-09-28 |
NO20042154L (no) | 2004-07-29 |
CN1608061A (zh) | 2005-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0103644D0 (sv) | Therapeutic isoquinoline compounds | |
SE0103649D0 (sv) | Therapeutic quinoline compounds | |
SE0103648D0 (sv) | Therapeutic quinolone compounds | |
WO2002055012A3 (en) | Therapeutic heterocyclic compounds | |
WO2002055013A3 (en) | Therapeutic chromone compounds | |
NZ514711A (en) | Compounds useful as anti-inflammatory agents | |
MY135688A (en) | Novel substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators | |
SG147472A1 (en) | N-thiazol-2-yl-benzamide derivatives | |
ATE393123T1 (de) | Herstellung von eisenverbindungen durch hydrothermale umwandlung | |
DE60130365D1 (de) | Die Verwendung von Rosiglitazon zur Behandlung von psychiatrischen Erkrankungen. | |
ATE282605T1 (de) | 2-thio-subsituierte imidazolderivative und ihre verwendung in der pharmazie | |
SE0103647D0 (sv) | Therapeutic chromone compounds | |
SE0103650D0 (sv) | Therapeutic heterocyclic compounds | |
CA2411412A1 (en) | Indole derivatives useful for the treatment of cns disorders | |
AU2002243419A1 (en) | Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators | |
DK1756066T3 (da) | Tetrasubstituerede imidazolderivater som canabinoid-CB1-receptormodulatorer med höj CB1/CB2-receptorundertypeselektivitet | |
IL160615A0 (en) | Novel piperidin-2,6-dione bisulphate salts and their use for the treatment of stress-related affective disorders | |
ATE330605T1 (de) | Piperidin-2,6-dionpamoat-salze und ihre verwendung zur behanldung von stressbedingten affektiven st rungen | |
DK1049672T3 (da) | Azetidincarboxamid-derivater til behandling af CNS-lidelser | |
NO20050146D0 (no) | N,N-disubstituerte diazocykloalkaner nyttige i behandling av CNS-forstyrrelser grunnet serotonergisk dysfunksjon | |
WO2002048105A3 (en) | Aryloxy piperidinyl derivatives for the treatment of depression | |
WO2003045917A3 (en) | Ccr-3 receptor antagonists vii | |
DE602004005863D1 (de) | 4-arylsulphonylpiperidin-derivate als 5-ht2a -rezeptor antagonisten | |
SI1603877T1 (sl) | Novi derivati aminopiridina kot antagonisti mGiuR5 | |
NO20026246D0 (no) | 2-aminoalkyl-tieno[2,3-d]pyrimidiner |